Georgia Wiesner, M.D., M.S., has joined Vanderbilt-Ingram Cancer Center (VICC) as professor of Medicine and director of the newly created Clinical and Translational Hereditary Cancer Program.
Combination therapy with two drugs delayed the development of treatment resistance in patients with metastatic melanoma that expresses a specific mutation in the BRAF gene.
Vanderbilt University Medical Center has been named the Employer of the Year for 2012 by the Tennessee Nurses Association (TNA).